Joshua Strauss, MD
In the second decision of its kind and magnitude in a matter of days, a major medical group has again recommended cutting back on cancer screening for women. On the …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
What is the Role of Drug Therapy in Treating Obesity?
November 19, 2009
Arlene Chung
Faculty Peer Reviewed
Despite the high prevalence of obesity1 and its associated morbidity2 and mortality 3,4, it represents one of the most difficult chronic conditions to treat. Barriers include a …
Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF.
November 17, 2009
Aalok Turakhia, MD
As the debate over when to begin screening mammography in women rages on, the United States Prevention Service Task Force (USPSTF) added fuel to the fire by releasing a new recommendation statement in …
PrimeCuts: This Week in the Journals
November 16, 2009
Katie Miro MD
Faculty peer reviewed
Americans took the time last week to honor the men and women who fought for our country as Veteran’s Day was marked with parades …
Therapeutic Hypothermia
November 12, 2009
Catherine Lucero, MD
Faculty peer reviewed
A recent article in the New York Times highlighted the remarkable recovery of a doctor who regained essentially all his mental function just six weeks after …
Clinical Correlations Awarded Gold eHealthcare Leadership Award
November 11, 2009We are very excited to announce that Clinical Correlations has been awarded the 2009 Gold eHealthcare Leadership Award. This awards program, now in it’s tenth year,  is the largest web-oriented awards program that is focused exclusively on healthcare. The program attracts over 1100 entrants. Clinical Correlations won this …
PrimeCuts: This Week in the Journals
November 9, 2009
Megha Shah MD
Faculty peer reviewed
Do we fail to make healthy choices simply because we lack information? If we knew that a tall sized Starbucks Caramel Frappuccino with …
Breaking News: FDA issues new warning for Exenatide (Byetta®)
November 5, 2009
Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
 Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve …